The enhancement of glycolytic pathways holds promise for early intervention
It is not listed in the FDA's Orange Book, and no Investigational New Drug (IND) application for BPC-157 has been publicly disclosed
Termination by Agile
Czechia Greater than 99.8 % purity confirmed by COA Assay content verified at 50.7 mg Endotoxin level below 0.001 EU/mg No detectable heavy metals or microbial contamination High-purity peptide for controlled laboratory research For research use only not for human or veterinary use For laboratory research only
Researchers exploring GHK-Cu alongside other regenerative and longevity focused compounds may also want to review our guide to 6 best peptides for anti-aging research, which places GHK-Cu in context alongside other frequently studied options
For musculoskeletal use, it is commonly considered for tendon irritation, ligament sprains, muscle strains, fascia-related pain, overuse injuries, and joint-adjacent soft-tissue pain